Wealth Alliance’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$417K Sell
792
-43
-5% -$24.1K 0.03% 363
2026
Q1
$469K Buy
835
+76
+10% +$48.7K 0.05% 308
2025
Q4
$513K Buy
759
+12
+2% +$8.17K 0.05% 296
2025
Q3
$477K Buy
747
+43
+6% +$26.1K 0.05% 313
2025
Q2
$378K Buy
+704
New +$337K 0.04% 354
2024
Q3
Sell
-460
Closed -$224K 537
2024
Q2
$224K Buy
460
+40
+10% +$20.1K 0.03% 457
2024
Q1
$227K Sell
420
-1
-0.2% -$546 0.03% 464
2023
Q4
$234K Buy
+421
New +$198K 0.03% 450
2023
Q3
Sell
-456
Closed -$229K 511
2023
Q2
$229K Buy
456
+41
+10% +$19.6K 0.03% 448
2023
Q1
$208K Buy
+415
New +$199K 0.03% 473
2021
Q4
Sell
-348
Closed -$216K 453
2021
Q3
$216K Sell
348
-124
-26% -$83.3K 0.05% 390
2021
Q2
$298K Sell
472
-29
-6% -$16K 0.07% 325
2021
Q1
$245K Sell
501
-388
-44% -$194K 0.07% 338
2020
Q4
$444K Buy
889
+352
+66% +$157K 0.13% 186
2020
Q3
$211K Sell
537
-72
-12% -$26.6K 0.08% 300
2020
Q2
$201K Buy
+609
New +$176K 0.08% 291

Other funds holding IDXX

Wealth Alliance's IDXX Position: Q2 2026 in Review

Wealth Alliance reduced its Idexx Laboratories (IDXX) stake by 5.1% in Q2 2026, selling an estimated $24.1K and leaving 792 shares worth $417K. The position accounts for 0.03% of the portfolio, ranked #363.

Wealth Alliance first reported a position in IDXX in Q2 2020 and has held it in 16 quarters since. The position peaked at $513K in Q4 2025. 1,305 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Wealth Alliance held 792 shares of Idexx Laboratories worth $417K as of Q2 2026.
  • Wealth Alliance sold 43 Idexx Laboratories shares in Q2 2026, an estimated $24.1K.
  • Idexx Laboratories made up 0.03% of Wealth Alliance's portfolio in Q2 2026, its #363 holding.
  • Wealth Alliance first reported a position in Idexx Laboratories in Q2 2020 and has held it in 16 quarters since.
  • Wealth Alliance's Idexx Laboratories position peaked at $513K in Q4 2025.
  • 1,305 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Wealth Alliance's 13F filing for Q2 2026, filed 11 Aug 2026.